Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ML-098
Cat. No.:
OB0225LY-0066
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
ML-098 is an immunomodulatory compound that plays a role in regulating the immune response of cells and suppressing inflammation.
Synonym:
878978-76-8; ML098; 1-[2-(2,5-Dimethylphenoxy)ethyl]indole-3-carboxylic acid; 1-[2-(2,5-Dimethylphenoxy)ethyl]-1H-indole-3-carboxylic acid; 1-(2-(2,5-Dimethylphenoxy)ethyl)-1H-indole-3-carboxylic acid; 1-[2-(2,5-Dimethylphenoxy)ethyl]-3-indolecarboxylic acid
CAS No.:
878978-76-8
Compound CID:
7345532
Formula:
C19H19NO3
Formula Weight:
309.36
Specification
Relative Density:
1.17 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ML-098 can be used for autoimmune disease research.
Library Information
Targets:
Ras
Receptors:
Rab7
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
g8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 161.6 mM
